Disclosure Panels Details Page
Colon/Rectal/Anal Cancers Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Frankie Algieri | None | None | None | None | 05/24/2023 |
| Nilofer Azad MD | Agios, Inc. Array Atlas Bayer HealthCare Bristol-Myers Squibb Company Celgene Corporation Daiichi- Sankyo Co. Debio Eli Lilly and Company EMD Serono Incyte Corporation Merck & Co., Inc. Taiho Pharmaceuticals Co., Ltd. |
AstraZeneca Pharmaceuticals LP GlaxoSmithKline Incyte Corporation Mirati QED |
AstraZeneca Pharmaceuticals LP | None | 01/05/2023 |
| Al Benson III MD,FASCO,FACP | AIM Immuno Tech Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Bristol-Myers Squibb Company GSK Mirati Mirati Therapeutics, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. PrECOG, LLC Tempus Terumo Therabionic |
Therabionic Artemida Bristol-Myers Squibb Company Janssen Oncology Natera Pfizer Inc./Hospira Inc. |
None | None | 05/09/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Yi-Jen Chen PhD,MD | None | None | None | None | 03/17/2023 |
| Kristen Ciombor MD | Array Bristol-Myers Squibb Company Calithera Daiichi- Sankyo Co. Genentech, Inc. Incyte Corporation Merck & Co., Inc. Nucana Pfizer Inc. |
Incyte Corporation Personalis Pfizer Inc. Replimune SeaGen |
None | None | 01/29/2023 |
| Stacey Cohen MD | GlaxoSmithKline | Bayer HealthCare Cancer Study Group Delcath Eisai Inc. Guidepoint Helsell Fettermann Istari Oncology |
None | None | 03/20/2023 |
| Harry Cooper MD | None | None | None | None | 01/17/2023 |
| Dustin Deming MD | Aadi Biosciences Arcus Bristol-Myers Squibb Company Curegenix Eli Lilly and Company EMD Serono Genentech, Inc. Ipsen Merck & Co., Inc. Natera Pfizer Inc. Promega Revolution Medicine Seattle Genetics, Inc. STRATA Oncology |
Bayer HealthCare Eli Lilly and Company Foundation Medicine Illumina Pfizer Inc. Seattle Genetics, Inc. |
None | None | 05/12/2023 |
| Ignacio Garrido-Laguna PhD,MD | Amgen Inc. Genentech, Inc. GlaxoSmithKline Halozyme, Inc. MedImmune Inc. Navire Novartis Pharmaceuticals Corporation Pfizer Inc. Seattle Genetics, Inc. SOTIO, LLC Tolero Trishula Yingli |
Cancer Study Group Jazz Pharmaceuticals Inc. Kanaph Therapeutics OncXerna |
None | None | 08/08/2022 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Jean Grem MD | Processa Pharmaceuticals | None | None | None | 01/12/2023 |
| Lisa Gurski PhD | None | None | None | None | 01/06/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| J. Randolph Hecht MD | A2 Amgen Inc. Astellas Pharma US, Inc. Bold Camrus Crinetics Exelixis Inc. Gilead Sciences, Inc. NGM TESARO, Inc. Tizona |
Actym Astellas Pharma US, Inc. Deciphera Pharmaceuticals, Inc. Exelixis Inc. Gilead Sciences, Inc. IGM Mirati Notch Rafael ZelamBio |
None | None | 03/05/2023 |
| Kyle Herrmann BSN,RN,OCN | None | None | None | None | 03/06/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Sarah Hoffe MD | Galera, second trial, GRECO-2 Varian Medical Systems, Inc. ViewRay |
Beyond the White Coat Galera University of South Florida |
MyCareGorithm Rittenhouse , I have signed a paper for future stock options but have not been received anything to this date |
None | 01/22/2023 |
| Steven Hunt MD | No commercial interest. This is a lab developed system for photoacoustic imaging of tumors. | None | None | None | 01/11/2023 |
| Hisham Hussan MD | None | None | None | None | 12/09/2022 |
| Kimberly Johung MD,PhD | None | None | None | None | 01/16/2023 |
| Nora Joseph MD | None | None | None | None | 12/19/2022 |
| Natalie Kirilcuk MD | None | None | None | None | 10/04/2022 |
| Smitha Krishnamurthi MD | Agenus Aravive Biologics, Inc BioMed Valley Bristol-Myers Squibb Company Natera Pfizer Inc. |
None | None | None | 01/14/2023 |
| Jennifer Maratt MD | None | None | None | None | 01/03/2023 |
| Wells Messersmith MD | ALX Oncology Amgen Inc. BeiGene CanBAS Criterium Exelixis Inc. Experimental Drug Development Centre (Singapore) Fate Therapeutics Mirati NGM Pfizer Inc. PureTech QED Therapeutics Rascal Therapeutics Zymeworks |
takeda | None | None | 01/13/2023 |
| Jeffrey Meyerhardt MD,MPH | None | None | None | None | 05/15/2023 |
| Eric Miller PhD,MD | EMD Serono | None | None | None | 04/11/2023 |
| Mary Mulcahy MD | None | None | None | None | 08/07/2022 |
| Steven Nurkin MS,MD,FACS | None | Merck & Co., Inc. | None | None | 01/06/2023 |
| Michael Overman MD | None | None | 3dmed AbbVie, Inc. agilvax Eisai Inc. Gilead Sciences, Inc. gritstone Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Phanes Takeda Pharmaceuticals North America, Inc. |
uptodate | 01/30/2023 |
| Aparna Parikh MS,MD | AbbVie, Inc. Bayer HealthCare Bristol-Myers Squibb Company C2i Checkmate CVS Daiichi- Sankyo Co. Delcath Eli Lilly and Company erasca Foundation Medicine Genentech, Inc. Inivata Karkinos Mirati Novartis Pharmaceuticals Corporation Parithera Pfizer Inc. PMV Pharma Puretech Saga Scare Seagen Taiho Pharmaceuticals Co., Ltd. Up to Date Value Analytics Lab |
C2i equity but no valuation yet Parithera Xcures XGenomes equity but no valuation yet |
None | None | 01/15/2023 |
| Sharon Park PharmD,BCOP | None | None | None | None | 05/09/2023 |
| Hitendra Patel MD | None | Epinoma | None | None | 08/17/2022 |
| Katrina Pedersen MS,MD | Arcus BioLineRx Boston Biomedical Bristol-Myers Squibb Company Daiichi- Sankyo Co. HCW Biologics Incyte Corporation Ipsen MedImmune Inc. Merck & Co., Inc. Natera Nouscom Novartis Pharmaceuticals Corporation Pfizer Inc. Pierre-Fabre Rafael Roche Laboratories, Inc. |
AstraZeneca Pharmaceuticals LP GlaxoSmithKline Novartis Pharmaceuticals Corporation SAGA Diagnostics Taiho Pharmaceuticals Co., Ltd. |
WebMD/MedScape | UpToDate | 03/02/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Leonard Saltz MD | None | Genor Biopharma | None | None | 05/22/2023 |
| Charles Schneider MD,FACP | None | None | None | None | 03/14/2023 |
| David Shibata MD,FACS,FASCRS | None | None | None | None | 05/26/2023 |
| John Skibber MD | None | None | None | None | 01/30/2023 |
| Jenna Snedeker MS | None | None | None | None | 01/19/2023 |
| Constantinos Sofocleous MD,PhD,FSIR,FCIRSE | Boston Scientific Corporation Ethicon, Inc. Memorial Sloan Kettering IMRAS NIH/NCI SIRTEX Society of Interventional Oncology |
Ethicon, Inc. Medtronic, Inc. TERUMO Varian Medical Systems, Inc. |
None | None | 12/23/2022 |
| Eden Stotsky-Himelfarb RN,BSN | None | None | None | None | 07/28/2021 |
| Anna Tavakkoli MD,MSc | None | None | None | None | 03/06/2023 |
| Alan Venook MD | Amgen Inc. | Amgen Inc. Bayer HealthCare Bristol-Myers Squibb Company Exact Sciences Exelixis Inc. GlaxoSmithKline Merck & Co., Inc. Pfizer Inc. |
None | None | 03/06/2023 |
| Erin Vidic | None | None | None | None | 02/13/2023 |
| Christopher Willett MD | None | None | None | None | 01/08/2023 |
| Grant Williams MSPH,MD | None | None | None | None | 01/22/2023 |
| Christina Wu MD | HutchMed Limited Pfizer Inc. Sirnaomics Xilis |
Exelixis Inc. SeaGen |
None | None | 05/21/2023 |